SRH Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Hold
267
0.07% 48
2025
Q4
$287K Hold
267
0.08% 47
2025
Q3
$204K Hold
267
0.06% 59
2025
Q2
$208K Hold
267
0.06% 55
2025
Q1
$221K Hold
267
0.07% 49
2024
Q4
$206K Hold
267
0.06% 59
2024
Q3
$237K Hold
267
0.07% 54
2024
Q2
$242K Hold
267
0.08% 51
2024
Q1
$208K Hold
267
0.07% 60
2023
Q4
$156K Hold
267
0.05% 67
2023
Q3
$143K Hold
267
0.07% 69
2023
Q2
$91.7K Hold
267
0.05% 87
2023
Q1
$92K Hold
267
0.05% 87
2022
Q4
$98K Sell
267
-167
-38% -$59.2K 0.05% 84
2022
Q3
$140K Hold
434
0.18% 67
2022
Q2
$141K Hold
434
0.17% 65
2022
Q1
$124K Hold
434
0.14% 79
2021
Q4
$120K Hold
434
0.14% 82
2021
Q3
$100K Sell
434
-166
-28% -$41K 0.12% 86
2021
Q2
$138K Hold
600
0.17% 72
2021
Q1
$112K Hold
600
0.16% 71
2020
Q4
$101K Hold
600
0.17% 69
2020
Q3
$89K Hold
600
0.17% 67
2020
Q2
$99K Hold
600
0.25% 60
2020
Q1
$83K Hold
600
0.23% 61
2019
Q4
$79K Hold
600
0.25% 65
2019
Q3
$67K Hold
600
0.23% 70
2019
Q2
$66K Hold
600
0.23% 71
2019
Q1
$78K Hold
600
0.28% 63
2018
Q4
$69K Hold
600
0.26% 65
2018
Q3
$64K Hold
600
0.22% 73
2018
Q2
$51K Hold
600
0.19% 84
2018
Q1
$46K Hold
600
0.18% 82
2017
Q4
$51K Hold
600
0.2% 76
2017
Q3
$51K Hold
600
0.22% 75
2017
Q2
$49K Hold
600
0.23% 66
2017
Q1
$50K Hold
600
0.23% 65
2016
Q4
$44K Hold
600
0.22% 69
2016
Q3
$48K Hold
600
0.25% 61
2016
Q2
$47K Hold
600
0.25% 60
2016
Q1
$43K Hold
600
0.24% 63
2015
Q4
$51K Hold
600
0.3% 55
2015
Q3
$50K Hold
600
0.29% 54
2015
Q2
$50K Hold
600
0.32% 51
2015
Q1
$44K Hold
600
0.29% 50
2014
Q4
$41K Hold
600
0.28% 54
2014
Q3
$39K Hold
600
0.3% 51
2014
Q2
$37K Hold
600
0.29% 53
2014
Q1
$35K Hold
600
0.28% 52
2013
Q4
$31K Buy
+600
New +$30K 0.31% 57

Other funds holding LLY

SRH Advisors's LLY Position: Q1 2026 in Review

SRH Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 267 shares worth $246K. The position accounts for 0.07% of the portfolio, ranked #48.

SRH Advisors first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $287K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SRH Advisors held 267 shares of Eli Lilly worth $246K as of Q1 2026.
  • SRH Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.07% of SRH Advisors's portfolio in Q1 2026, its #48 holding.
  • SRH Advisors first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
  • SRH Advisors's Eli Lilly position peaked at $287K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SRH Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.